This comprehensive guide explains how eflornithine (formerly branded as Vaniqa) works to reduce unwanted facial hair by inhibiting a key enzyme in hair follicles, with clinical studies showing significant results in 58% of patients after eight weeks of use. While Vaniqa has been discontinued, the same active ingredient remains available through Oana Health at $46 per month (paid quarterly), offering an effective solution for the 40% of women who deal with unwanted facial hair and its emotional impacts.

This blog post discusses medical treatments for hirsutism, a condition causing excessive facial hair growth in women typically due to hormonal imbalances like PCOS, with a focus on both oral medications (like spironolactone) and topical solutions (like eflornithine cream).

Topical metformin (or Metformin cream) is a novel form of a well-known drug, applied directly to the skin to potentially reduce gastrointestinal side effects common with oral metformin. It has shown promise in treating PCOS (polycystic ovary syndrome) by helping to regulate menstrual cycles, reduce androgen levels, and potentially improve fertility.